ASAB - Stragenics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue-16.289-49.257
Cost of Revenue-8.184-40.628
Gross Profit-8.105-8.629
Operating Expenses
Research Development----
Selling General and Administrative50.353121.4323.084330.655
Non Recurring----
Total Operating Expenses50.353133.6163.084371.358
Operating Income or Loss-50.353-117.327-3.084-322.101
Income from Continuing Operations
Total Other Income/Expenses Net124.827-471.119--221.791
Earnings Before Interest and Taxes-50.353-117.327-3.084-322.101
Interest Expense-258.622-141.413-141.413-945.071
Income Before Tax74.474-588.446-3.084-543.892
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops74.474-588.446-3.084-543.892
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income74.474-588.446-3.084-543.892
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares74.474-588.446-3.084-543.892